Imexpharm

Imexpharm Book Value Growth

The Book Value Growth of Imexpharm (IMP.VN) as of Oct 26, 2026 is 5.65 %. In the previous year, Book Value Growth was 4.73 % — a change of 19.58% (higher).

Book Value Growth

5.65 %

YoY

19.58%

Last updated:

Book Value Growth of Imexpharm is 2025 5.65 % . Book Value Growth of Imexpharm was 2024 4.73 % . It decreases by 19.58% higher compared to the previous year.

The Imexpharm Book Value Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value Growth
Date
Book Value Growth
Jan 1, 2018
7.83 VND
Jan 1, 2019
3.61 VND
Jan 1, 2020
11.01 VND
Jan 1, 2021
3.69 VND
Jan 1, 2022
5.57 VND
Jan 1, 2023
10.04 VND
Jan 1, 2024
4.73 VND
Jan 1, 2025
5.65 VND
The Imexpharm Book Value Growth history
YEARBook Value GrowthYoY
5.65 %+19.58%
4.73 %-52.90%
10.04 %+80.03%
5.57 %+50.92%
3.69 %-66.44%
11.01 %+205.14%
3.61 %-53.95%
7.83 %-84.04%
49.09 %+1,430.39%
3.21 %-76.81%
13.83 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Book Value Growth of Imexpharm is 5.65 % in 2025.

On Eulerpool you can find the complete historical development of Book Value Growth Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Book value growth measures the percentage increase in shareholders' equity. It indicates how effectively the company retains and grows its net assets.

To evaluate Book Value Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Book Value Growth.

Book Value Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Book Value Growth's Imexpharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Imexpharm

All Key Metrics — Imexpharm